InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,561.27
(
-0.48%
)
US TECH 100
19,194.60
(
-0.40%
)
Dow Jones
40,921.42
(
-0.67%
)
Brent Oil
84.48
(
-0.01%
)
Bitcoin
63,750.53
(
-0.52%
)
Post# of 252636
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: masterlongevity post# 120708

Sunday, 05/29/2011 12:06:17 PM

Sunday, May 29, 2011 12:06:17 PM

Post# of 252636
One more concern I see about bapi phase II data is the lack of dose response related to efficacy* (in contrast to safety where vasogenic edema was dose-related).

*Both efficacy and vasogenic edema were related to ApoE4.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up